These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16870716)

  • 1. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.
    Vitale S; Cambien B; Karimdjee BF; Barthel R; Staccini P; Luci C; Breittmayer V; Anjuère F; Schmid-Alliana A; Schmid-Antomarchi H
    Gut; 2007 Mar; 56(3):365-72. PubMed ID: 16870716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
    Brueckmann M; Borggrefe M
    Gut; 2007 Mar; 56(3):314-6. PubMed ID: 17339240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
    Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
    Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
    Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
    Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
    Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
    Tang L; Hu HD; Hu P; Lan YH; Peng ML; Chen M; Ren H
    Gene Ther; 2007 Aug; 14(16):1226-34. PubMed ID: 17597794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells.
    Xin H; Kanehira M; Mizuguchi H; Hayakawa T; Kikuchi T; Nukiwa T; Saijo Y
    Stem Cells; 2007 Jul; 25(7):1618-26. PubMed ID: 17412895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
    Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
    Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
    Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2.
    Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN
    Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine in vascular biology: from basic research to clinical disease.
    Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer.
    Endo T; Toda M; Watanabe M; Iizuka Y; Kubota T; Kitajima M; Kawakami Y
    Cancer Gene Ther; 2002 Feb; 9(2):142-8. PubMed ID: 11857031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine expression in human renal inflammation.
    Cockwell P; Chakravorty SJ; Girdlestone J; Savage CO
    J Pathol; 2002 Jan; 196(1):85-90. PubMed ID: 11748646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and analysis of mice lacking the chemokine fractalkine.
    Cook DN; Chen SC; Sullivan LM; Manfra DJ; Wiekowski MT; Prosser DM; Vassileva G; Lira SA
    Mol Cell Biol; 2001 May; 21(9):3159-65. PubMed ID: 11287620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.